Meet REPHAEL, the world’s first predictive wearable for hospital at home

REPHAEL doesn’t just monitor – it predicts, detects, and alerts about life-threatening conditions early, before issues escalate, and enables preventive action for safe hospital care at home.

REPHAEL is the only platform in the world that:

Provides all the actionable data doctors need to make informed decisions remotely.
Delivers the standard of intensive care monitoring to any location where the patient is.
Predicts and alerts in advance to risks such as:
- Respiratory failure
- Heart failure
- Sepsis
- Falls
Empowers healthcare systems to provide exceptional care from the comfort of home, reducing hospital admissions and significantly cutting healthcare costs.

Revolutionizing Remote Health Surveillance

From unique signals to actionable clinical insights

REPHAEL is an award-winning non-invasive, end-to-end, in-and-out-of-hospital, ICU-level multi-indication remote patient monitoring platform. Utilizing patented multi-sensor and unique algorithms that sense and

analyze various physiological changes such as the diaphragm’s electrical activity; the AI-based
system empowers medical teams to seamlessly anticipate and prevent ARDS and respiratory insufficiency.

Unique Clinical Applications

ICU-level telemetry redefined

Anywhere, Continuous, and Cost-Effective—Replaces Dozens of Expensive Monitors with a Single Wearable.

Prediction of respiratory failure

Total savings of $176,137 per year per patient

Early sepsis screening

25% reduction in overall mortality

Over 200 Years’
Accumulated Experience

ATLASense is led by a team of world-renowned Israeli healthcare and MedTech experts, with extensive international experience. The company focuses on improving the quality of clinical decisions for better care and efficiency of health care systems worldwide.

Our Technology

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal. It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using.